Skip to main content
Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie 9/2016

01.09.2016 | Continuing Professional Development

Hypertensive disorders of pregnancy

verfasst von: Ana Sjaus, MD, Dolores M. McKeen, MD, Ronald B. George, MD

Erschienen in: Canadian Journal of Anesthesia/Journal canadien d'anesthésie | Ausgabe 9/2016

Einloggen, um Zugang zu erhalten

Abstract

Purpose

In this continuing professional development module, we review recent Society of Obstetricians and Gynaecologists of Canada (SOGC) guidelines for the classification and diagnosis of hypertensive disorders of pregnancy (HDP) as well as review the clinical features, laboratory investigations, and outcomes of HDP. We explore the evidence for anesthetic management and prevention of end-organ damage in women with HDP and describe the role and contribution of anesthesiologists as part of a multidisciplinary care team.

Principal findings

Hypertensive disorders of pregnancy can have variable presentations with clinical signs and symptoms that often do not correlate with the underlying severity and progression of the disease. Failure of timely diagnosis and treatment contributes significantly to adverse maternal (neurologic complications, pulmonary edema, and postpartum hemorrhage) and neonatal (respiratory and neurologic complications and stillbirth) outcomes. In the Canadian context, improvements in medical care have led to better maternal and neonatal outcomes. Timing of delivery is crucial in balancing maternal risks and fetal benefits of ongoing pregnancy. Evidence-based SOGC guidelines regarding diagnosis and management of HDP address many aspects of clinical care relevant to anesthesiologists, who have an important role in the multidisciplinary care team.

Conclusions

Hypertensive disorders of pregnancy are on the rise worldwide, and this trend is expected to continue. The major contributors to maternal mortality are failure to recognize HDP promptly or to treat the condition adequately. It is essential that anesthesiologists understand the disease process and acquire knowledge of the guidelines governing current obstetrical care in order to provide evidence-based multidisciplinary quality care to these patients. Anesthetic management helps prevent potentially deleterious maternal and fetal outcomes.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens 2010; 28: 1349-55.CrossRefPubMed Carty DM, Delles C, Dominiczak AF. Preeclampsia and future maternal health. J Hypertens 2010; 28: 1349-55.CrossRefPubMed
5.
Zurück zum Zitat Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens 2014; 4: 105-45. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy (HDP) Working Group. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. Pregnancy Hypertens 2014; 4: 105-45.
6.
Zurück zum Zitat Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy Working Group . Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014; 36: 416-41. Magee LA, Pels A, Helewa M, Rey E, von Dadelszen P; Canadian Hypertensive Disorders of Pregnancy Working Group . Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy: executive summary. J Obstet Gynaecol Can 2014; 36: 416-41.
7.
Zurück zum Zitat English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control 2015; 8: 7-12.PubMedPubMedCentral English FA, Kenny LC, McCarthy FP. Risk factors and effective management of preeclampsia. Integr Blood Press Control 2015; 8: 7-12.PubMedPubMedCentral
8.
Zurück zum Zitat Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-74.CrossRefPubMed Khan KS, Wojdyla D, Say L, Gulmezoglu AM, Van Look PF. WHO analysis of causes of maternal death: a systematic review. Lancet 2006; 367: 1066-74.CrossRefPubMed
10.
Zurück zum Zitat Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 2011; 66: 497-506.CrossRefPubMed Raymond D, Peterson E. A critical review of early-onset and late-onset preeclampsia. Obstet Gynecol Surv 2011; 66: 497-506.CrossRefPubMed
11.
Zurück zum Zitat American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122: 1122-31. American College of Obstetricians and Gynecologists; Task Force on Hypertension in Pregnancy. Hypertension in pregnancy. Report of the American College of Obstetricians and Gynecologists’ Task Force on Hypertension in Pregnancy. Obstet Gynecol 2013; 122: 1122-31.
12.
Zurück zum Zitat National Institute for Health and Clinical Excellence. Hypertension in pregnancy: diagnosis and management. NICE Clinical Guideline 107. London: Excellence. National Institute for Health and Clinical Excellence; 2010. Available from URL: https://www.nice.org.uk/guidance/cg107 (accessed May 2016). National Institute for Health and Clinical Excellence. Hypertension in pregnancy: diagnosis and management. NICE Clinical Guideline 107. London: Excellence. National Institute for Health and Clinical Excellence; 2010. Available from URL: https://​www.​nice.​org.​uk/​guidance/​cg107 (accessed May 2016).
13.
Zurück zum Zitat Committee on Obstetric Practice. Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2015; 125: 521-5.CrossRef Committee on Obstetric Practice. Committee Opinion No. 623: Emergent therapy for acute-onset, severe hypertension during pregnancy and the postpartum period. Obstet Gynecol 2015; 125: 521-5.CrossRef
14.
16.
Zurück zum Zitat Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009; 374: 979-88.CrossRefPubMed Koopmans CM, Bijlenga D, Groen H, et al. Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia after 36 weeks’ gestation (HYPITAT): a multicentre, open-label randomised controlled trial. Lancet 2009; 374: 979-88.CrossRefPubMed
17.
Zurück zum Zitat Broekhuijsen K, van Baaren GJ, van Pampus MG, et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 2015; 385: 2492-501.CrossRefPubMed Broekhuijsen K, van Baaren GJ, van Pampus MG, et al. Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial. Lancet 2015; 385: 2492-501.CrossRefPubMed
19.
Zurück zum Zitat Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105: 246-54.CrossRefPubMed Martin JN Jr, Thigpen BD, Moore RC, Rose CH, Cushman J, May W. Stroke and severe preeclampsia and eclampsia: a paradigm shift focusing on systolic blood pressure. Obstet Gynecol 2005; 105: 246-54.CrossRefPubMed
20.
Zurück zum Zitat Snyder SW, Cardwell MS. Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol 1989; 161: 35-6.CrossRefPubMed Snyder SW, Cardwell MS. Neuromuscular blockade with magnesium sulfate and nifedipine. Am J Obstet Gynecol 1989; 161: 35-6.CrossRefPubMed
21.
Zurück zum Zitat Ben-Ami M, Giladi Y, Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol 1994; 101: 262-3.CrossRefPubMed Ben-Ami M, Giladi Y, Shalev E. The combination of magnesium sulphate and nifedipine: a cause of neuromuscular blockade. Br J Obstet Gynaecol 1994; 101: 262-3.CrossRefPubMed
22.
Zurück zum Zitat Magee LA, Miremadi S, Li J, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005; 193: 153-63.CrossRefPubMed Magee LA, Miremadi S, Li J, et al. Therapy with both magnesium sulfate and nifedipine does not increase the risk of serious magnesium-related maternal side effects in women with preeclampsia. Am J Obstet Gynecol 2005; 193: 153-63.CrossRefPubMed
23.
Zurück zum Zitat Bateman BT, Polley LS. Hypertensive disorders. In: Chestnut DH, Wong CA, Tsen LC, Ngan Kee WD, Beilin Y, Mhyre J (Eds). Chestnut’s Obstetric Anesthesia: Principles and Practice, 5th ed. Philadelphia: Saunders; 2014: 825-59. Bateman BT, Polley LS. Hypertensive disorders. In: Chestnut DH, Wong CA, Tsen LC, Ngan Kee WD, Beilin Y, Mhyre J (Eds). Chestnut’s Obstetric Anesthesia: Principles and Practice, 5th ed. Philadelphia: Saunders; 2014: 825-59.
24.
Zurück zum Zitat Matrooshi N, Ali N, Abdalla MS, Pathikkaran PA, Sinha S. Propofol for status epilepticus in pregnancy. J Neurol Stroke 2015; 3: 00108. Matrooshi N, Ali N, Abdalla MS, Pathikkaran PA, Sinha S. Propofol for status epilepticus in pregnancy. J Neurol Stroke 2015; 3: 00108.
25.
Zurück zum Zitat Dam AK, Mishra JC, Shome PK. Treatment of refractory seizures in eclampsia with propofol: a case report. Indian J Crit Care Med 2003; 7: 283-4. Dam AK, Mishra JC, Shome PK. Treatment of refractory seizures in eclampsia with propofol: a case report. Indian J Crit Care Med 2003; 7: 283-4.
26.
Zurück zum Zitat Crozier TM, Wallace EM, Parkin WG. Haemodynamic assessment in pregnancy and pre-eclampsia: a Guytonian approach. Pregnancy Hypertens 2015; 5: 177-81.PubMed Crozier TM, Wallace EM, Parkin WG. Haemodynamic assessment in pregnancy and pre-eclampsia: a Guytonian approach. Pregnancy Hypertens 2015; 5: 177-81.PubMed
27.
Zurück zum Zitat Henke VG, Bateman BT, Leffert LR. Focused review: spinal anesthesia in severe preeclampsia. Anesth Analg 2013; 117: 686-93.CrossRefPubMed Henke VG, Bateman BT, Leffert LR. Focused review: spinal anesthesia in severe preeclampsia. Anesth Analg 2013; 117: 686-93.CrossRefPubMed
28.
Zurück zum Zitat Dennis AT. Management of pre-eclampsia: issues for anaesthetists. Anaesthesia 2012; 67: 1009-20.CrossRefPubMed Dennis AT. Management of pre-eclampsia: issues for anaesthetists. Anaesthesia 2012; 67: 1009-20.CrossRefPubMed
29.
Zurück zum Zitat DesRoches JM, McKeen DM, Warren A, et al. Anesthetic management guided by transthoracic echocardiography during cesarean delivery complicated by hypertrophic cardiomyopathy. A A Case Rep 2015; 6: 154-9.CrossRef DesRoches JM, McKeen DM, Warren A, et al. Anesthetic management guided by transthoracic echocardiography during cesarean delivery complicated by hypertrophic cardiomyopathy. A A Case Rep 2015; 6: 154-9.CrossRef
30.
Zurück zum Zitat Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008; 52: 873-80.CrossRefPubMed Valensise H, Vasapollo B, Gagliardi G, Novelli GP. Early and late preeclampsia: two different maternal hemodynamic states in the latent phase of the disease. Hypertension 2008; 52: 873-80.CrossRefPubMed
31.
Zurück zum Zitat Cantwell R, Clutton-Brock T, Cooper G, et al. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118(Suppl 1): 1-203.PubMed Cantwell R, Clutton-Brock T, Cooper G, et al. Saving Mothers’ Lives: Reviewing maternal deaths to make motherhood safer: 2006-2008. The Eighth Report of the Confidential Enquiries into Maternal Deaths in the United Kingdom. BJOG 2011; 118(Suppl 1): 1-203.PubMed
32.
Zurück zum Zitat Mehrabadi A, Liu S, Bartholomew S, et al. Hypertensive disorders of pregnancy and the recent increase in obstetric acute renal failure in Canada: population based retrospective cohort study. BMJ 2014; 349: g4731.CrossRefPubMedPubMedCentral Mehrabadi A, Liu S, Bartholomew S, et al. Hypertensive disorders of pregnancy and the recent increase in obstetric acute renal failure in Canada: population based retrospective cohort study. BMJ 2014; 349: g4731.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Leffert LR . What’s new in obstetric anesthesia? Focus on preeclampsia. Int J Obstet Anesth 2015; 24: 264-71. Leffert LR . What’s new in obstetric anesthesia? Focus on preeclampsia. Int J Obstet Anesth 2015; 24: 264-71.
34.
Zurück zum Zitat Park BY, Jeong CW, Jang EA, et al. Dose-related attenuation of cardiovascular responses to tracheal intubation by intravenous remifentanil bolus in severe pre-eclamptic patients undergoing Caesarean delivery. Br J Anaesth 2011; 106: 82-7.CrossRefPubMed Park BY, Jeong CW, Jang EA, et al. Dose-related attenuation of cardiovascular responses to tracheal intubation by intravenous remifentanil bolus in severe pre-eclamptic patients undergoing Caesarean delivery. Br J Anaesth 2011; 106: 82-7.CrossRefPubMed
35.
Zurück zum Zitat Yoo KY, Kang DH, Jeong H, et al. A dose-response study of remifentanil for attenuation of the hypertensive response to laryngoscopy and tracheal intubation in severely preeclamptic women undergoing caesarean delivery under general anaesthesia. Int J Obstet Anesth 2013; 22: 10-8.CrossRefPubMed Yoo KY, Kang DH, Jeong H, et al. A dose-response study of remifentanil for attenuation of the hypertensive response to laryngoscopy and tracheal intubation in severely preeclamptic women undergoing caesarean delivery under general anaesthesia. Int J Obstet Anesth 2013; 22: 10-8.CrossRefPubMed
36.
Zurück zum Zitat Wasden SW, Ragsdale ES, Chasen ST, Skupski DW. Impact of non-steroidal anti-inflammatory drugs on hypertensive disorders of pregnancy. Pregnancy Hypertens 2014; 4: 259-63.PubMed Wasden SW, Ragsdale ES, Chasen ST, Skupski DW. Impact of non-steroidal anti-inflammatory drugs on hypertensive disorders of pregnancy. Pregnancy Hypertens 2014; 4: 259-63.PubMed
37.
Zurück zum Zitat Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326: 845.CrossRefPubMedPubMedCentral Wilson BJ, Watson MS, Prescott GJ, et al. Hypertensive diseases of pregnancy and risk of hypertension and stroke in later life: results from cohort study. BMJ 2003; 326: 845.CrossRefPubMedPubMedCentral
Metadaten
Titel
Hypertensive disorders of pregnancy
verfasst von
Ana Sjaus, MD
Dolores M. McKeen, MD
Ronald B. George, MD
Publikationsdatum
01.09.2016
Verlag
Springer US
Erschienen in
Canadian Journal of Anesthesia/Journal canadien d'anesthésie / Ausgabe 9/2016
Print ISSN: 0832-610X
Elektronische ISSN: 1496-8975
DOI
https://doi.org/10.1007/s12630-016-0689-8

Weitere Artikel der Ausgabe 9/2016

Canadian Journal of Anesthesia/Journal canadien d'anesthésie 9/2016 Zur Ausgabe

Aquatherapie bei Fibromyalgie wirksamer als Trockenübungen

03.05.2024 Fibromyalgiesyndrom Nachrichten

Bewegungs-, Dehnungs- und Entspannungsübungen im Wasser lindern die Beschwerden von Patientinnen mit Fibromyalgie besser als das Üben auf trockenem Land. Das geht aus einer spanisch-brasilianischen Vergleichsstudie hervor.

Endlich: Zi zeigt, mit welchen PVS Praxen zufrieden sind

IT für Ärzte Nachrichten

Darauf haben viele Praxen gewartet: Das Zi hat eine Liste von Praxisverwaltungssystemen veröffentlicht, die von Nutzern positiv bewertet werden. Eine gute Grundlage für wechselwillige Ärzte und Psychotherapeuten.

Beutel versus Maschine: Beste Beatmungstechnik bei Herzstillstand gesucht

02.05.2024 Kardiopulmonale Reanimation Nachrichten

Stehen die Chancen auf eine Rückkehr der Spontanzirkulation nach Herz-Kreislauf-Stillstand bei manueller oder maschineller Beatmung besser? Und unterscheidet sich das neurologische Outcome nach der Reanimation? Das belgische Herzstillstand-Register liefert die Daten für einen direkten Vergleich zwischen Beutel und Beatmungsgerät.

Tipps für den Umgang mit Behandlungsfehlern

01.05.2024 DGIM 2024 Kongressbericht

Es ist nur eine Frage der Zeit, bis es zu einem Zwischenfall kommt und ein Behandlungsfehler passiert. Doch wenn Ärztinnen und Ärzte gut vorbereitet sind, schaffen es alle Beteiligten den Umständen entsprechend gut durch diese Krise. 

Update AINS

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.